MicroRNA-1246 regulates the radio-sensitizing effect of curcumin in bladder cancer cells via activating P53

Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer

(2017) J. Alfred Witjes et al.   EUROPEAN UROLOGY

Tp53 and its potential therapeutic role as a target in bladder cancer

(2017) Chiara Ciccarese et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Bladder-sparing radiotherapy for muscle-invasive bladder cancer: A survey of providers to determine barriers and enablers

(2017) Melanie Walker et al.   RADIOTHERAPY AND ONCOLOGY

Upregulation of MicroRNA-1246 Is Associated with BRAF Inhibitor Resistance in Melanoma Cells with Mutant BRAF

(2017) Jae-Hyeon Kim et al.   Cancer Research and Treatment

Cancer statistics in China, 2015

(2016) Wanqing Chen et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma

(2016) Sujata Sakha et al.   Scientific Reports

MicroRNA in radiotherapy: miRage or miRador?

(2015) E Korpela et al.   BRITISH JOURNAL OF CANCER

Down-regulation of miR-1246 in cervical cancer tissues and its clinical significance

(2015) Y. Yang et al.   GYNECOLOGIC ONCOLOGY

The protective role of curcumin on testicular tissue after hindlimb ischemia reperfusion in rats

(2015) Mohammad Ashrafzadeh Takhtfooladi et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

MicroRNA-1246 promotes growth and metastasis of colorectal cancer cells involving CCNG2 reduction

(2015) SAI WANG et al.   Molecular Medicine Reports

Theracurmin® efficiently inhibits the growth of human prostate and bladder cancer cells via induction of apoptotic cell death and cell cycle arrest

(2015) MINYONG KANG et al.   ONCOLOGY REPORTS

p53-induced microRNA-1246 inhibits the cell growth of human hepatocellular carcinoma cells by targeting NFIB

(2015) QUAN ZHANG et al.   ONCOLOGY REPORTS

Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma

(2013) N Takeshita et al.   BRITISH JOURNAL OF CANCER

Expression of p53 family genes in urinary bladder cancer: correlation with disease aggressiveness and recurrence

(2013) Danae Papadogianni et al.   TUMOR BIOLOGY

miR-148a regulates osteoclastogenesis by targeting V-maf musculoaponeurotic fibrosarcoma oncogene homolog B

(2012) Peng Cheng et al.   JOURNAL OF BONE AND MINERAL RESEARCH

p53 downregulates Down syndrome-associated DYRK1A through miR-1246

(2011) Yu Zhang et al.   EMBO REPORTS

Lessons Learned From 1,000 Neobladders: The 90-Day Complication Rate

(2010) Richard E. Hautmann et al.   JOURNAL OF UROLOGY

RETRACTED: Curcumin potentiates the antitumor effects of gemcitabine in an orthotopic model of human bladder cancer through suppression of proliferative and angiogenic biomarkers

(2009) Sheeja T. Tharakan et al.   BIOCHEMICAL PHARMACOLOGY

A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humans

(2009) Hui Li et al.   JOURNAL OF CLINICAL INVESTIGATION

Effects of curcumin on bladder cancer cells and development of urothelial tumors in a rat bladder carcinogenesis model

(2008) Binqiang Tian et al.   CANCER LETTERS